vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Twin Vee PowerCats, Co. (VEEE). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.0M, roughly 1.3× Twin Vee PowerCats, Co.). On growth, Twin Vee PowerCats, Co. posted the faster year-over-year revenue change (60.4% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -24.3%).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

Twin Vee PowerCats Co. is a leading manufacturer of high-performance recreational power catamaran boats. The company offers a diverse lineup of catamaran models suited for leisure cruising, fishing, water sports, and commercial marine use, serving customers primarily across North America, with a growing distribution network in global coastal markets.

IRD vs VEEE — Head-to-Head

Bigger by revenue
IRD
IRD
1.3× larger
IRD
$3.9M
$3.0M
VEEE
Growing faster (revenue YoY)
VEEE
VEEE
+70.6% gap
VEEE
60.4%
-10.2%
IRD
Faster 2-yr revenue CAGR
IRD
IRD
Annualised
IRD
50.3%
-24.3%
VEEE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRD
IRD
VEEE
VEEE
Revenue
$3.9M
$3.0M
Net Profit
$-2.6M
Gross Margin
3.7%
Operating Margin
-87.7%
Net Margin
-85.6%
Revenue YoY
-10.2%
60.4%
Net Profit YoY
53.0%
-119.0%
EPS (diluted)
$-1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
VEEE
VEEE
Q4 25
$3.9M
$3.0M
Q3 25
$3.1M
$3.4M
Q2 25
$2.9M
$4.8M
Q1 25
$4.4M
$3.6M
Q4 24
$4.3M
$1.9M
Q3 24
$3.9M
$2.9M
Q2 24
$1.1M
$4.3M
Q1 24
$1.7M
$5.3M
Net Profit
IRD
IRD
VEEE
VEEE
Q4 25
$-2.6M
Q3 25
$-17.5M
$-2.8M
Q2 25
$-7.4M
$-1.7M
Q1 25
$-8.2M
$-1.6M
Q4 24
$-1.2M
Q3 24
$-7.5M
$-3.0M
Q2 24
$-7.8M
$-4.5M
Q1 24
$-7.1M
$-2.3M
Gross Margin
IRD
IRD
VEEE
VEEE
Q4 25
3.7%
Q3 25
-1.3%
Q2 25
13.8%
Q1 25
14.9%
Q4 24
-57.6%
Q3 24
-5.0%
Q2 24
4.7%
Q1 24
5.3%
Operating Margin
IRD
IRD
VEEE
VEEE
Q4 25
-87.7%
Q3 25
-269.9%
-81.0%
Q2 25
-309.0%
-35.2%
Q1 25
-227.2%
-46.5%
Q4 24
-224.9%
Q3 24
-207.1%
-107.3%
Q2 24
-748.9%
-107.7%
Q1 24
-450.5%
-48.2%
Net Margin
IRD
IRD
VEEE
VEEE
Q4 25
-85.6%
Q3 25
-566.9%
-80.4%
Q2 25
-257.5%
-34.8%
Q1 25
-187.5%
-44.6%
Q4 24
-62.7%
Q3 24
-194.6%
-103.7%
Q2 24
-698.3%
-104.4%
Q1 24
-415.3%
-44.3%
EPS (diluted)
IRD
IRD
VEEE
VEEE
Q4 25
$-1.19
Q3 25
$-0.25
$-1.23
Q2 25
$-0.12
$-0.87
Q1 25
$-0.24
$-1.08
Q4 24
$-3.51
Q3 24
$-0.29
$-2.64
Q2 24
$-0.30
$-3.09
Q1 24
$-0.29
$-1.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
VEEE
VEEE
Cash + ST InvestmentsLiquidity on hand
$45.1M
$1.4M
Total DebtLower is stronger
$499.9K
Stockholders' EquityBook value
$15.3M
$13.5M
Total Assets
$50.2M
$16.2M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
VEEE
VEEE
Q4 25
$45.1M
$1.4M
Q3 25
$30.8M
$2.7M
Q2 25
$32.4M
$6.0M
Q1 25
$41.8M
$4.9M
Q4 24
$30.3M
$7.5M
Q3 24
$36.6M
$11.1M
Q2 24
$41.4M
$14.9M
Q1 24
$47.2M
$17.1M
Total Debt
IRD
IRD
VEEE
VEEE
Q4 25
$499.9K
Q3 25
$499.9K
Q2 25
$499.9K
Q1 25
$499.9K
Q4 24
$499.9K
Q3 24
$499.9K
Q2 24
$499.9K
Q1 24
$499.9K
Stockholders' Equity
IRD
IRD
VEEE
VEEE
Q4 25
$15.3M
$13.5M
Q3 25
$6.0M
$15.9M
Q2 25
$17.5M
$18.6M
Q1 25
$5.1M
$17.7M
Q4 24
$6.7M
$19.2M
Q3 24
$34.3M
$17.4M
Q2 24
$40.6M
$19.6M
Q1 24
$46.1M
$22.3M
Total Assets
IRD
IRD
VEEE
VEEE
Q4 25
$50.2M
$16.2M
Q3 25
$36.1M
$18.9M
Q2 25
$38.7M
$22.4M
Q1 25
$48.2M
$23.6M
Q4 24
$36.9M
$25.9M
Q3 24
$40.4M
$30.1M
Q2 24
$44.8M
$33.8M
Q1 24
$51.8M
$36.5M
Debt / Equity
IRD
IRD
VEEE
VEEE
Q4 25
0.04×
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
VEEE
VEEE
Operating Cash FlowLast quarter
$-35.3M
$-1.7M
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-62.5%
Capex IntensityCapex / Revenue
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
VEEE
VEEE
Q4 25
$-35.3M
$-1.7M
Q3 25
$-6.2M
$-2.6M
Q2 25
$-10.3M
$-745.6K
Q1 25
$-9.0M
$-1.7M
Q4 24
$-25.6M
$-2.3M
Q3 24
$-5.1M
$-2.4M
Q2 24
$-7.3M
$-482.1K
Q1 24
$-5.7M
$-1.7M
Free Cash Flow
IRD
IRD
VEEE
VEEE
Q4 25
$-1.9M
Q3 25
$-3.1M
Q2 25
$-1.5M
Q1 25
$-2.6M
Q4 24
$-3.6M
Q3 24
$-3.7M
Q2 24
$-2.2M
Q1 24
$-3.7M
FCF Margin
IRD
IRD
VEEE
VEEE
Q4 25
-62.5%
Q3 25
-91.2%
Q2 25
-30.6%
Q1 25
-71.0%
Q4 24
-192.8%
Q3 24
-128.8%
Q2 24
-51.0%
Q1 24
-70.9%
Capex Intensity
IRD
IRD
VEEE
VEEE
Q4 25
4.6%
Q3 25
14.0%
Q2 25
14.9%
Q1 25
22.9%
Q4 24
68.8%
Q3 24
45.8%
Q2 24
39.9%
Q1 24
37.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons